BOM/542650 (BOM/542650)

Bombay Stock Exchange: BOM/542650 · INR

₹552

+1.30 (+0.2%)· Recorded snapshot

Market cap	114.5B
Revenue (ttm)	17.1B
Net income (ttm)	2B
EPS (ttm)	₹10.1
P/E (trailing)	54.6x
P/E (forward)	41.8x
Dividend	₹2.00 (0.36%)
Volume	82,669

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 17.1B
Net income (ttm): 2B
EPS (ttm): ₹10.1
P/E (trailing): 54.6x
P/E (forward): 41.8x
Market cap: 114.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E41.8

P25 n/aP50 n/aP75 n/a

Trailing P/E54.6

P25 n/aP50 n/aP75 n/a

ROE13.4

P25 n/aP50 n/aP75 n/a

ROIC13.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/542650 indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

INR

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-04
Employees	4,484
Employees change	-339
Employees growth	-7.03%
Enterprise value	INR 114.9B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1980
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	INE112L01020
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2026-03-20
Last stock split type	Forward
Market cap	INR 114.5B
Next earnings date	2026-11-04
Price	INR 551.65
Price currency	INR
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	bom/542650
Website	https://www.metropolisindia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	55.03x
Average P/E ratio (10Y)	58.59x
Average P/E ratio (3Y)	63.02x
Average P/E ratio (5Y)	58.64x
Earnings yield	1.83%
EV/Earnings	56.84x
EV/EBIT	39.84x
EV/EBITDA	28.48x
EV/FCF	37.31x
EV/Sales	6.7x
FCF / EV yield	2.68%
FCF yield	2.69%
Forward P/E	41.8x
Graham number	126.73438
Graham upside	-76.97%
Industry forward P/E	50.75x
Industry P/E	65.25x
Lynch fair value	INR 48.58
Lynch upside	-91.17%
P/(FCF - SBC) ratio	38.18x
P/(OCF - SBC) ratio	33.33x
P/B ratio	7.49x
P/E ratio	54.64x
P/FCF ratio	37.17x
P/OCF ratio	32.56x
P/S ratio	6.68x
Price / tangible book value	35.46x
Price/EBITDA ratio	35.76x
Sector forward P/E	36.12x
Sector P/E	45.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.82%
EBITDA margin	18.68%
Effective tax rate	26.42%
FCF margin	18.67%
Gross margin	77.74%
Operating margin	16.82%
Pretax margin	16.12%
Profit margin	11.79%
Profit per employee	INR 449,653
Profitable quarters	33
Profitable years	13
Revenue per employee	INR 3.8M
ROA	8.36%
ROA (5Y)	9.14%
ROCE	14.85%
ROE	13.37%
ROE (5Y)	15.96%
ROIC	13.63%
ROIC (5Y)	15.69%
SBC / revenue	0.49%
Tax / revenue	4.26%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	37.11%
EPS growth (Q)	12.7%
EPS growth (QoQ)	-0.78%
EPS growth 3Y	14.46%
EPS growth 5Y	-4.08%
EPS growth quarters	5
EPS growth years	2
FCF growth	40.06%
FCF growth 3Y	16.47%
FCF growth 5Y	6.83%
Gross profit growth	22.51%
Gross profit growth (Q)	18.27%
Gross profit growth 3Y	14.92%
Gross profit growth 5Y	8.68%
Net income growth	32.58%
Net income growth (Q)	25.76%
Net income growth (QoQ)	11.32%
Net income growth 3Y	13.39%
Net income growth 5Y	-4.59%
Net income growth quarters	5
Net income growth years	2
OCF growth	33.47%
OCF growth 3Y	12.38%
OCF growth 5Y	7.09%
Operating income growth	42.93%
Operating income growth (Q)	33.74%
Operating income growth 3Y	13.17%
Operating income growth 5Y	-2.66%
Revenue growth	21.8%
Revenue growth (Q)	16.62%
Revenue growth (QoQ)	6.01%
Revenue growth 3Y	14.29%
Revenue growth 5Y	7.67%
Revenue growth quarters	12
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -434.9M
Depreciation and amortization	INR 317.1M
EBIT	INR 2.9B
EBITDA	INR 3.2B
EPS	INR 10.10
Financing cash flow	INR -1.2B
Free cash flow	INR 3.1B
Free cash flow minus SBC	INR 3B
Gross profit	INR 13.3B
Income taxes	INR 728.4M
Investing cash flow	INR -2.2B
Net borrowing	INR -767.3M
Net cash flow	INR 153.1M
Net income	INR 2B
Operating cash flow minus SBC	INR 3.4B
Operating income	INR 2.9B
Revenue	INR 17.1B
Stock-based compensation	INR 80.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 72.98
Debt / EBITDA	0.58
Debt / equity	0.15
Debt / FCF	0.75
Interest coverage	11.27
Net cash (debt)	INR -289.5M
Net cash / market cap	-0.25%
Net debt / EBITDA	0.09
Net debt / equity	0.02
Net debt / FCF	0.09
Piotroski F-Score	7
Shareholders' equity	INR 15.2B
Tangible book value	INR 3.2B
Tangible book value per share	INR 15.53
Total cash	INR 2B
Total debt	INR 2.3B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.82
Current ratio	1.4
Inventory turnover	7.99
Quick ratio	1.12
Working capital	INR 1.3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.3%
Dividend growth	0%
Dividend growth (3Y)	0%
Dividend growth (5Y)	0%
Dividend growth years	0
Dividend payment date	2026-06-12
Dividend payment years	2
Dividend per share	INR 2.00
Dividend yield	0.36%
Ex-dividend date	2026-05-19
Last dividend	INR 1.00
Payout ratio	19.81%
Shareholder yield	3.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 536.45
1D price change	0.24%
1M price change	-5.4%
1M total return	-5.4%
1W price change	2.91%
1W total return	2.91%
1Y price change	12.75%
1Y return CAGR	13.22%
1Y total return	13.21%
20-day SMA	INR 536.61
200-day SMA	INR 520.69
3M price change	-4.74%
3M total return	-4.74%
3Y price change	58.91%
3Y return CAGR	16.95%
3Y total return	59.95%
50-day SMA	INR 561.44
50-day SMA vs 200-day SMA	50over200
52-week high	INR 608.95
52-week high date	2026-07-30
52-week low	INR 413.00
52-week low date	2026-04-02
5Y price change	-22.86%
5Y return CAGR	-4.75%
5Y total return	-21.58%
6M price change	15.33%
6M total return	15.56%
All-time high	INR 894.75
All-time high date	2021-12-30
All-time low	INR 226.21
All-time low date	2019-05-14
Average true range (ATR)	INR 20.48
Average volume	11.9K
Change from 52-week high	-9.41%
Change from 52-week low	33.57%
Change from all-time high	-38.49%
Change from all-time low	143.29%
Change from open	-0.6%
Day's gap	0.84%
Dollar volume	INR 45.6M
High price	INR 563.10
Low price	INR 546.40
Monthly RSI	57.45
Open price	INR 555.00
Position in 52-week range	31.44%
Previous close	INR 550.35
Price vs 150-day SMA	2.59%
Price vs 20-day SMA	2.56%
Price vs 200-day SMA	5.7%
Price vs 50-day SMA	-1.98%
Relative volume	6.96
RSI	52.79
Sharpe ratio	0.48
Sharpe ratio (3Y)	0.47
Sharpe ratio (5Y)	-0.08
Sortino ratio	0.97
Sortino ratio (3Y)	0.95
Sortino ratio (5Y)	0.05
Volume	82.7K
Weekly RSI	52.14
YTD price change	14.11%
YTD total return	14.34%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	106.2M
Shares change (QoQ)	12.24%
Shares change (YoY)	-3.3%
Shares held by insiders	18.07%
Shares held by institutions	46.91%

Deeper analysis on BOM/542650

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/542650 report

Is a complete BOM/542650 research report available?

No complete published report is available for bom/542650 (BOM/542650) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/542650 (BOM/542650)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/542650

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/542650 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/542650

Frequently asked questions